Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Featured Research
    • Protamine shows...

    Protamine shows promise for new types of contact lens disinfectant

    Written by supriya kashyap kashyap Published On 2016-11-09T10:46:45+05:30  |  Updated On 9 Nov 2016 10:46 AM IST
    Protamine shows promise for new types of contact lens disinfectant

    Protamine a natural protein with a proven safety record may be useful in developing new types of disinfectant solutions for contact lenses, according to a study published in the November issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.




    In laboratory tests, protamine solutions perform at least as well as current disinfectant solutions in killing microbes that can cause contact lens-related infections, according to the report by Mahesh K. Bandara, PhD, and colleagues of University of New South Wales, Sydney. But more research will be needed to assess the safety and effectiveness of protamine-containing solutions before they are adopted for broader use in contact lens care.


    Protamine Kills Microbes Including Causes of Contact Lens Infections


    The researchers performed a series of experiments to evaluate the antimicrobial effects of protamine solutions, with and without additives commonly used in contact lens disinfectant products. Originally derived from salmon, protamine is already used for other medical purposes especially as an antidote to the anti-blood clotting drug heparin.


    Following industry standards, the study tested protamine solutions for antimicrobial activity against a standard laboratory panel of microbes, as well as against organisms isolated from patient samples. Potential toxic effects on cultured cells were evaluated as well.


    The results showed significant antimicrobial effects of protamine solutions. The effects were "dose-dependent" the higher the protamine concentration, the greater the microbe-killing effectiveness. Protamine killed a wide range of bacteria, yeasts, and fungi, including common causes of contact lens-related infections.


    Against most organisms, protamine was even more effective in solutions containing common additives. In standard tests, the antimicrobial effects of protamine were comparable to those of commercially available contact lens disinfectant solutions. All solutions tested had minimal toxicity indicating that they also had a good safety profile.


    Infections of the cornea the clear, outermost layer of the eye are a potentially serious complication of contact lens wear. Many different risk factors have been identified, including poor contact lens cleaning and disinfection routines.


    Millions of people worldwide use multipurpose disinfecting solutions to disinfect, clean, rinse, and store their contact lenses. However, these solutions may not always be effective against bacteria and other organisms. With its broad spectrum of antimicrobial activity and long history of medical use, protamine could be a useful alternative for use in contact lens care products.


    "This study highlights the potential for protamine to be used for the development of effective multipurpose disinfection solutions," Dr. Bandara and colleagues conclude. At least in laboratory studies, protamine solutions have a "progressive dose-dependent killing effect" on bacteria and other organisms that can cause corneal infections.


    "Protamine represents a new strategy and a very different type of compound to help defend against ocular infections related to contact lens use," comments Michael Twa, OD, PhD, FAAO, Editor-in-Chief of Optometry and Vision Science. Further research will be needed to evaluate protamine's stability, compatibility with contact lens materials, and safety for use with contact lens care products and the eye.



    contact lenscontact lens disinfectantDr Mahesh K Bandarajournal of the American Academy of OptometryMichael TwaProtamine
    Source : Optometry and Vision Science

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok